California Attorney General Bill Lockyer has filed a suit against 39 drug companies for overcharging Medi-Cal (Medicaid) for drugs. I certainly commend Lockyear's action. As expected, the Corporate fascists have come rushing to defend this taxpayer exploitation by pharmaceutical companies. And the arguments always come from the same old broken record -- reducing Big Pharm's taxpayer exploitation will stifle "innovation" and "research."
Here's the link to the story:
http://news.yahoo.com/news?tmpl=story&u=/nm/20050825/ts_nm/california_lawsuit_dc_2 Drug company payment from taxpayer-funded programs is nothing but Corporate Welfare. Drug companies shouldn't be profiteering off of taxpayer's dollars. It's not "free enterprise" when payment for an item comes from a 3rd party payer. There's no supply-and-demand effect whatsoever. The patient receiving the drug doesn't reduce his demand for the drug when the price the State of California pays for the medication increases. So sales of drug do NOT decline from price increases, like they would in a truly "free" market. Drug companies exploit this situation as much as possible.
Prices paid for drugs by government agencies should be tightly regulated, the way doctor's fees are regulated.
The only "innovations" we currently see from pharmaceutical companies are new ways to market old drugs, and "innovative" ways to bend the law and extend patent protection.
Drug companies are making exorbitant profits off the backs of California and U.S. taxpayers. They whine about "onerous" regulations, except regulations that protect their profits.
The truth is that most government regulations are designed to protect corporate profits, not to protect the people. Pharmaceutical company protections are the most egregious example of these Corporatocratic policies.
Pharmaceutical companies spend huge amounts of their "innovation" money on unfairly extending patents, as well as the unethical direct advertising to the public. They have EXCESSIVE money in their coffers. They have more than enough money to finance research. Unfortunately, they squander that money on advertising, lobbying, and attempting to circumvent patent laws.
unlawflcombatnt